Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
about
Nucleotide metabolism, oncogene-induced senescence and cancer.Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies.NF-Y activates genes of metabolic pathways altered in cancer cells.RRM2B-Mediated Regulation of Mitochondrial Activity and Inflammation under Oxidative Stress.Metabolic alterations accompanying oncogene-induced senescence.Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cellsTargeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts.Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine.Control of Nucleotide Metabolism Enables Mutant p53's Oncogenic Gain-of-Function Activity.Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.Cellular Senescence in the Treatment of Ovarian Cancer.
P2860
Q33969333-500DF68B-1172-418E-8C27-DB04DCED0D78Q37665228-9E5D052A-C98C-4513-92D9-69CC71A6A05CQ38218536-3B73688F-36B2-4B7C-A98E-5EB3CDB2A8B2Q38294889-9916D2BD-2BBE-4392-94BD-EDEC79A903FAQ38862308-E3821420-512E-48CF-B2DF-A19AF29A9E42Q38866719-EC2FFA7F-C911-4FBF-8FCD-398BE95013CBQ39434311-4124F628-E65F-4EF6-A74B-9C9F4A786ACAQ39837844-E9837FAF-6FE5-4834-A854-2F0F6EADD1B3Q41105052-C6BAE845-14E4-47EC-95D5-46A9182F9685Q42107201-376507D9-4F7A-47AD-9D61-CB95063AF4EDQ47130816-8486AAF6-D84E-4CEA-AB5A-E545773D8312Q47238975-8F9A643F-21DC-4E65-BD65-3C92280E5019Q53688741-4C08BF0A-F24B-4D3E-801D-27E744ECB242Q53692066-63F8F81A-D44B-4DDB-A362-3CAFC342239B
P2860
Identification of ribonucleotide reductase M2 as a potential target for pro-senescence therapy in epithelial ovarian cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 29 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Identification of ribonucleoti ...... y in epithelial ovarian cancer
@en
Identification of ribonucleoti ...... in epithelial ovarian cancer.
@nl
type
label
Identification of ribonucleoti ...... y in epithelial ovarian cancer
@en
Identification of ribonucleoti ...... in epithelial ovarian cancer.
@nl
prefLabel
Identification of ribonucleoti ...... y in epithelial ovarian cancer
@en
Identification of ribonucleoti ...... in epithelial ovarian cancer.
@nl
P2093
P2860
P356
P1433
P1476
Identification of ribonucleoti ...... y in epithelial ovarian cancer
@en
P2093
Frances Xin
Katherine M Aird
Panagiotis A Konstantinopoulos
Rugang Zhang
P2860
P304
P356
10.4161/CC.26953
P577
2013-10-29T00:00:00Z